Psychosocial and Medical Aspects of Systematic Lupus Erythematosus (SLE)

• Conditions: lupus; SLE; 10003816

• Registration Number: NL-OMON32104
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 38

Inclusion Criteria

A diagnosis of proliferative lupus nephritis and a received treatment according to either the NIH or the Euro-Lupus protocol.

Exclusion Criteria

Patients with proliferative lupus-nephritis who were not treated according to the NIH- or Euro-Lupus protocol and patients with a diagnosis of non-proliferative lupus nephritis are excluded from the study.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The most important study parameter is the difference in quality of life between<br /><br>patients that received the NIH treatment and patients that were treated<br /><br>according to the Euro-Lupus schema. Analysis of the drawings will encover which<br /><br>parameters are of meaning, thus in which the two groups differ from each<br /><br>other.<br /><br>In addition, the relation between the level of HRQol and illness perceptions as<br /><br>well as disease activity parameters will be investigated. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The presence of chimeric cells in blood of the female participants.</p><br>